Vinay Shah - 20 Jun 2023 Form 4/A - Amendment Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Chief Financial Officer
Signature
/s/ Vinay Shah
Issuer symbol
VRPX
Transactions as of
20 Jun 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
16 Aug 2023, 17:00:09 UTC
Date Of Original Report
21 Jun 2023
Previous filing
25 Jan 2022
Next filing
31 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 20 Jun 2023 Common Stock 100,000 $0.9900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option will vest after 12 months of continuous service, and the remaining 75% of the shares subject to the Option will vest in equal monthly installments over the next 24 months of continuous service